Thu, Jul 10, 2014, 4:48 AM EDT - U.S. Markets open in 4 hrs 42 mins

Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • fizrwinnr11 fizrwinnr11 Nov 4, 2012 10:08 PM Flag

    Pfizer portfolio update

    12/31/10 - 262,215 - ($17.51) Year-end 2010 close
    12/31/11 - 481,195 - ($21.64) Year-end 2011 close

    01/03 - 488,645 - ($21.97) RSI 69.5
    01/12 - 501,920 - ($21.99) RSI 65.8
    02/01 - 488,525 - ($21.31) Ex-dividend 22 cents, RSI 47.1
    02/06 - 471,285 - ($20.95) 2012 valuation low, RSI 43.4
    03/30 - 555,110 - ($22.65) RSI 72.9, an interim 2012 high
    04/13 - 527,300 - ($21.85) 9 straight losing sessions, RSI 45.4
    04/27 - 577,965 - ($23.08) RSI 70.0
    05/04 - 555,335 - ($22.38) RSI 47.7
    05/09 - 559,605 - ($22.45) Ex-dividend 22 cents, RSI 56.3
    05/10 - 574,430 - ($22.83) Tofacitinib recommended, RSI 64.0
    06/05 - 524,015 - ($21.60) RSI 33.6, lowest in ten months
    07/02 - 604,505 - ($23.00) RSI 65.6
    07/11 - 576,620 - ($22.34) RSI 45.5
    07/19 - 633,095 - ($23.80) RSI 72.2
    07/25 - 616,455 - ($23.33) RSI 58.6
    07/27 - 639,325 - ($23.83) RSI 67.0
    08/01 - 638,820 - ($23.94) Ex-dividend 22 cents, RSI 70.1
    08/03 - 650,580 - ($24.28) RSI 73.9
    08/07 - 641.145 - ($23.74) Bapi fails, RSI 59.0
    08/15 - 652,925 - ($24.04) RSI 62.1
    08/21 - 644,640 - ($23.69) RSI 52.1
    09/13 - 672,300 - ($24.25) RSI 59.6
    09/14 - 658,780 - ($23.80) RSI 47.8
    10/18 - 710,540 - ($26.04) RSI 76.2, highest since Q3-06
    10/19 - 709,575 - ($25.76) RSI 66.5
    10/23 - 697,390 - ($25.19) RSI 51.2
    10/26 - 702,325 - ($25.43) RSI 55.0
    11/02 - 674,250 - ($24.55) RSI 39.6, lowest in almost five months



    Up 39.6%. 2012 Portfolio gain to date based on $221,130 valuation increase less $2,250 interest
    Up 33.8%. 2012 Portfolio gain to date based on return on invested capital
    Up 16.5%. 2012 Pfizer stock price gain to date including three 22-cent dividends

    Up 12.4%. S & P 500 gain to date (1,258 to 1,414)



    Note: This portfolio had a steady cost basis of $100,000 from 11/17/04 inception through 6/2/08. From that date through mid-March of 2009, additional funds were invested until the cost basis reached $296,110. The basis has remained steady again since that time.

    Note: This portfolio was up by as much as 96K pre-crash on 6/1/07 with the stock closing at $27.68 that day. It was also down as much as 333K on 3/2/09 when the stock closed at $11.66. Gains of 415K from inception were seen on 10/18/12 with the stock at $26.04. Current gains are 378K.

    Note: Over time, the leverage factor at these portfolio levels is about 1.9, the lowest since inception. It was designed at the end of 2011 to go up by about 59K per Pfizer point up to $25 on the stock and then 53K a point thereafter. .

    Note: Average annualized gains from inception stands at 10.5% and considers all additional funds needed to margin the naked puts.

    Sentiment: Buy

 
PFE
30.05-0.10(-0.33%)Jul 9 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Gigamon Inc.
NYSEWed, Jul 9, 2014 4:04 PM EDT
TherapeuticsMD, Inc.
NYSE MKTWed, Jul 9, 2014 4:02 PM EDT